Beauty Company Annie International: Providing over 4.5 million masks weekly in response to COVID-19, but it wasn’t easy

By Graziella DiNuzzo Published June 3, 2020 World Trade Center of Greater Philadelphia

Before the COVID-19 pandemic hit, Annie International’s website showed a beautiful model wearing lipstick, now the model wears a mask.

For the past 27 years, Annie International, with headquarters in North Wales, PA, has serviced the beauty industry providing hair, skin, nail, and makeup products to 49 countries.

In mid-March, when the United States was in the early weeks of the global pandemic, Annie knew it was time to switch production of their Personal Protection Equipment (PPE), primarily used by salon workers, to include surgical and medical-grade products – especially masks.

​Annie created an official division – Annie Medical PPE

But it wasn’t easy.

Steven Miller, Executive Director of Sales and Operations explained the challenging process, “There were countless obstacles that we faced throughout the whole process. COVID-19 really showcased how unprepared the world is when it comes to each country being able to sustain itself with essential products.”

Testing to meet National Institute for Occupational Safety and Health (NIOSH) Standards

“We had to start the long process and invest 10s of thousands of dollars to have our products tested at Nelson Labs, a globally recognized lab. Many of our products have FDA, CE and ISO certifications among others but we quickly learned that many doctors and insurance companies require NIOSH certification, formed by the CDC.  When the world is in crisis and needs immediate PPE there should be a process to streamline this testing.  In the meantime doctors, nurses and other healthcare workers had to resort to not wearing PPE, wearing the same PPE or wearing a homemade PPE, while we have medical and surgical grade PPE’s ready and willing to donate and/or sell.

Obtaining KN95 Approval in USA

“The standard in the US is the N95 mask.  The N95 is made in America, the KN95 is made in China and the KF94 is made in Korea.  These three masks are the most common and widely used medical grade masks in the world.  Because N95 masks were not readily available in America the last two options were the KF94 and KN95. Fortunately China still allowed KN95 masks and surgical masks to be exported to other countries, and they soon were allowed in America. Japan, Australia, Mexico, UK, Europe and America all started immediately getting supplies from China as there was/is no other source.”

Quality of Product 
 
“The first obstacle was securing quality production. Many factories, brokers and resellers were and still are marketing imposter products using fake certifications and test results. We have representatives from Annie International on the ground in China verifying product, cutting open masks, and then the Quality Control process happens again here in America. When it comes to face masks the key ingredient is a filtration material called meltblown.  This textile became a major commodity. Having true meltblown and at the right thickness (grams) in each mask is essential.”
Supply Chain Production Availability
“Many countries closed their borders for exporting and American manufacturers were not permitted to export PPE out of the country. The problem is most countries did not have a large enough stock pile nor did they have large enough manufacturing capabilities to keep up with the demand.  China was the one country remaining open to export PPE but that supply chain was fluid daily and sometimes changed by the hour. Our only option to keep our supply chain at Annie International going was through our partnership with our factories in China.”

Labeling & Package Requirements and Certifications
 
“Laws, required certifications, and labeling & packaging requirements changed daily and weekly in some cases.  We had to repackage a shipment that went through customs at the airport and was ready to leave, due to packaging/labeling requirements that changed.”

Customs Delays

Shipments were being held in customs for long lengths of times due to the extreme high volume of PPE and because of changing regulations.”

Missing Product from Shipment

When dealing with a healthcare system, national chain store, major distributor or union this shortage can be dealt with.  When dealing with a government contract this shortage is an issue when you come up short.”


High Demand, High Freight Costs, Not enough Planes

“Standard air freight went from around $2/KG up to $26/KG.  This is outrageous. 

The main freight carriers such as DHL, UPS and FedEx would only accept shipments up to a certain weight.  Large shipments had to rely on airlines, which either stopped flying into and/or carrying freight from China.  As the airlines dropped off one by one over the weeks companies were fighting for space on planes, driving up cost.  At one point Amazon, being the largest airline customers, took all of the flights out of China for 1-3 weeks while our product sat waiting.”

Cash Up Front

 “Ten to twenty-year relationships with factories didn’t matter. If you have/had terms with a factory those terms were not applicable when it came to PPE.  The global supply chain for PPE’s became and still is cash-based market.  You must wire 50% of the cash at time of placing a PO and then the remaining 50% at completion of production before shipment.   Some factories were requiring 100% upfront before production.  Large National Retailers, Governments and militaries from countries all around the world, and major medical systems are and were not prepared.

Despite the challenges, Annie Medical PPE division currently provides 4.5 million + masks to the world – weekly. A portion of every shipment sold is donated to local grocery stores, police departments, township employees and healthcare workers throughout Pennsylvania. 

​While the United States maintains PPE export restrictions, Annie has been able to use its distribution centers around the world and leverage established relationships in 49 countries to direct ship PPE to its international customers. ​

​“We have been providing the Mexican Government in Mexico City with millions of masks per shipment to support their healthcare system due to COVID-19.  The Mexican Government had to also meet the new “playing rules” and wire the money in advance before receiving the product.  When the product arrived police and military escort then took it to the social security procurement.  We have done this with many countries such as Jamaica, the Dominican Republic, South Africa, UK, and France.”

“We have always been in the business of PPE products, just not to the level of what the country and world needs now,” Miller emphasized.

And while Miller calls the global PPE market “the wild wild west,” he admits the challenges are worth it to save lives. 

0 Comments

Kibow Biotech open during COVID-19 pandemic: dedicated to boosting immune health

By Graziella DiNuzzo

Dr. Rangan, Founder, Kibow Biotech in his lab in Newtown Square, PA

The phone rang and I was startled to hear her voice. “Thank you for calling Kibow Biotech, how may I help you?” she asked. I couldn’t find words. After weeks of working remotely during COVID-19, I wasn’t used to the sound of a receptionist’s voice.

I laughed and explained why and she patiently connected me with Mahesh.

“Yes, I am at the office, we are open for business,” Mahesh replied when I asked. “We are busy.”

Mahesh Ranganathan, International Product Manager leads the international sales for his family-owned company Kibow Biotech, Inc. located in Newtown Square Pennsylvania.

“We have 20 employees here and currently 4 are in the office to field phone orders. We haven’t had any layoffs and in fact, we are looking to recruit additional marketing, sales and research associates.”

Founded in 1997 by Mahesh’s father, Dr. Rangan, Kibow Biotech researches and develops scientifically-formulated and clinically-tested probiotic dietary supplements for maintaining kidney health and boosting the immunity of the geriatric population by restoring their intestinal microflora.

The name Kibow was derived from KI – for Kidney and BOW – for bowels and the product line includes: Renadyl™Kibow Fortis®Kibow Flora, and Azodyl

“We currently sell online and through other online distributors via amazon and their respective website. Not in brick and mortar. We sell to a 65 percent mix of consumers direct and about 35 percent to HealthCare professionals direct.”

During this COVID-19 pandemic, news reports repeatedly mention the need to maintain healthy immune systems to fight COVID-19.  “We have seen renewed interest in our Kibow Flora and a slight increase in sales,” Mahesh confirms. “Gut Microflora are responsible for boosting immunity and overall well-being of a person.”

Kibow’s website describes, Kibow Flora as providing a natural immune system boost.  “Kibow Flora ™is a highly effective probiotic supplement that contains 30 billion live probiotic bacteria per capsule. Kibow Flora is 100% natural and is enteric coated to ensure that the probiotic bacteria are not destroyed by gastric or bile acids before they are released into the bowel.”

“We have a 14-day window for shipping but then our products need to be refrigerated. Many probiotics you find in stores don’t have the same potency as ours.”

Kibow’s highest selling product is Renadyl™, a natural supplement which helps to metabolize nitrogenous waste that has diffused from the bloodstream into the bowel. “We’ve developed our products to serve niche markets. Older populations with kidney health issues and diabetes don’t have a lot of treatment options.”

Another Kibow product, Kibow Fortis®  was developed as prebiotic to stimulate the growth of the “good” bacteria, namely, the lactobacilli and the bifidobacteria.

Azodyl™  is a Kibow product developed specifically for cats and dogs to slow down uremic toxin buildup and helps prevent kidney damage. The supplement is also distributed and marketed by a French company, Vétoquinol.

“The World Trade Center of Greater Philadelphia has been key with International Trade rep support and informational resources provided to help our international expansions efforts.”

The top international markets for Kibow include Mexico, India, and the Philippines, “there is a large diabetic population in these regions.”

“International sales via distribution average about 100,000 customers. We have about 25,000 US.”

In January 2020, Mahesh attended Arab Health, one of the largest healthcare trade shows in Dubai, “ I had no idea, what was happening. Germs discriminate and affect populations unequally. The virus is a hidden epidemic of weakened immune systems. Public policy must focus on people’s ability to withstand infection.”  

Part of Kibow’s company vision statement, “is to advance the welfare of people globally by providing superior probiotic supplements.”

Kibow offers a phone ordering option for older populations that prefer speaking with a knowledgeable customer service representative.

And a friendly receptionist who answers the phone from an office during a pandemic.

Navigating Logistics During COVID-19. WTCGP’s “Got Questions” Featuring BDP’s Michael Ford provided some answers

By Graziella DiNuzzo also appeared on WTCGP Blog

​“The good news is that companies are exporting, products are leaving the US, going ocean and air, “ explained Michael Ford, Vice President of Government and Industry Affairs for BDP International, as he led the inaugural WTCGP Got Questions? digital series on April 16th.

President Linda Conlin welcomed nine company executives who signed up to get up- to-date information on logistics, “amidst this unprecedented pandemic member and client companies are looking for answers, and WTCGP is lining up the experts to provide some answers, even if its “don’t know yet.”

Throughout his successful career, Ford has helped companies navigate ever-changing import and export documentation and complex regulatory compliance. Ford has been with BDP for 40 of the companies’ 53-year existence. A privately owned and operated company, BDP’s mission is to deliver logistics solutions and transportation services – and they are busy.

In 2019, the WTCGP helped export companies with over $128 million in export sales, according to documented export sales reports. “We are committed to ensuring that our companies have the resources to succeed amidst this new normal,” said Conlin.

The reality is, “what has always been in place is now upside down,” said Ford to the attentive zoom meeting audience.

“Companies are having new experiences. Same person who is importing chemicals is now importing safety equipment, masks etc. – something outside of their scope of work,” Ford explains referring to the high demand of PPE (Personal Protection Equipment). “We are seeing a humanitarian position from companies to deliver health and medical supplies and what it means to work quickly to reinvent your company.”

“Trucks are busy, busy, busy on the roads working really hard to meet increasing demands for food. It’s a bit easier now that everyone is off the road.”

Rob Hutchison, President, Visual Software was pleased to learn, “more about logistics than he ever knew.”

With Rob’s focus on bringing technology to remote areas in Africa and his need to ship thousands of laptops, Ford’s suggestions were quite insightful.

“Since the international passenger air travel restrictions, more passenger planes can be used for air freight,” Ford explains. “Companies can take advantage of the best price and best service.”

The new reality for ocean freight was also discussed. “January, February and March, we have seen carrier ships bypassing China. Ships are returning to the US with empty containers.”

What does the future hold?

Ford urged the audience to “communicate, pick up the phone and re-establish relationships with your clients.”

“We are all under pressure. We need to ride this out together and it’s time to humanize what we are dealing with.”

Philadelphia Scientist and President of Epitek Inc., Dr. Steven Baranowitz, awarded US Government patents for the treatment of viral infections including Coronavirus, Pandemic Influenza, and Zika

Media Contact: Graziella DiNuzzo, gdinuzzo@wtcphila.org, 609.680.7670

Philadelphia, PA….April 20, 2020….Dr. Steven Baranowitz, President of Epitek, and a member of the World Trade Center of Greater Philadelphia, has been awarded two patents by the United States government, on March 31, 2020 and earlier on August 20, 2019, for treating viral infections, including Coronavirus, Pandemic Influenza, and Zika.  

“These broad-spectrum antiviral drugs include some medications currently marketed as prescription drugs (such as MMF/MPA) for other diseases, as well as a pipeline of drugs, some of which have been in clinical trials for other conditions,” says Dr. Baranowitz.

Dr. Baranowitz is seeking partnerships with doctors, hospitals, private companies, or government agencies to study the use of these medications in emergency clinical trials for the treatment of coronavirus patients.

With the help of World Trade Center of Greater Philadelphia (WTCGP) trade specialist, Dale Foote, Dr. Baranowitz has been working with PA Authorized Trade Representatives, in Germany (covering Italy, Austria and Switzerland), South Korea, and India to locate health and hospital officials who will want to learn more.

 “There are medications currently available by prescription in the US which are documented to kill most coronavirus strains in the laboratory. The medications are sold for a different use but could be clinically tested in the US to treat patients. They are anti-viral in a dose smaller than the dose for the current use,” says Dr. Baranowitz.

The medications have been demonstrated by Baranowitz to be broad spectrum antivirals, in collaboration with the National Institutes of Health (NIH), over the last 4 years. Dr Baranowitz has 28 years of drug development experience in the pharmaceutical industry, and believes that physicians, hospitals, state and federal government could use these medications rapidly in new emergency clinical trials.

Epitek focuses on two drugs documented to kill most Coronaviruses. The drugs are CURRENTLY MARKETED for a completely different use. One is widely available and inexpensive. For anti-viral effect, Epitek believes that the drug can be used at 10% or less of the dose for the currently marketed indication. The drugs inhibit inosine monophosphate dehydrogenase (IMPDH), which is a critical enzyme for increasing the body’s pool of the nucleoside guanosine. Guanosine is indispensable to the virus for replicating its RNA.

“A COVID research paper was published a few weeks ago by a different research group, saying that mycophenolic acid (MPA), which is the active ingredient in mycophenolate mofetil (MMF) is a good candidate for clinical testing,” says Dr. Baranowitz

About Steven A. Baranowitz MD MS MBA President

The President of Epitek is Dr. Steven Baranowitz. Dr Baranowitz is a successful Pharmaceutical/Biotech Scientist, Physician, and an entrepreneur with many patents to his credit. Having served as Medical Director at several major Pharmaceutical companies, as well as Biotechs, Dr. Baranowitz brings a wealth of industry experience with both large and small companies. He is a recognized expert in pharmaceutical Drug Safety and Clinical Trials and has consulted for many well known companies in these areas. He worked ensuring the safety of Vaccines, both marketed and in development, as a consultant to Sanofi-Pasteur in the past.

Dr. Baranowitz is an inventor with over ten US and International patents on new potential treatments for a variety of diseases in fields including virology, oncology, ophthalmology, and regenerative medicine.

A graduate of the New York University School of Medicine, Dr. Baranowitz completed specialty training in dermatology at Mount Sinai Hospital in New York.

He obtained research expertise in Developmental Biology while earning his Master of Science degree from the University of Michigan in Ann Arbor and his Bachelor of Science degree at Brooklyn College. His business training included the M.B.A. he obtained from Fairleigh-Dickinson University and his licensing and product evaluation experience at several pharmaceutical companies.

Dr. Baranowitz was honored by the University of Oxford in England when its Center for Mathematical Biology sponsored him as a visiting scientist. As a guest of the University, he lectured and collaborated in original research. During his stay, he also gave an invited guest seminar at the National Institute for Medical Research in London.

He continues actively collaborating in research with the National Institutes of Health, the Armed Forces Radiobiology Research Institute, and Temple University; he has in the past conducted research at U.S. Oak Ridge National Laboratory.

Dr. Baranowitz has presented papers at international symposia and his research has been published in several scientific journals including the Journal of Theoretical Biology, Macromolecules, and the New England Journal of Medicine.

Dr. Baranowitz continues active research at his office in Philadelphia, which is adjacent to Drexel University. Over 35 Drexel undergraduate and graduate coops (interns) have been trained by him in the last five years, and this educational and research collaboration is ongoing. Dr. Baranowitz is a resident of Wyncote, PA.

About the World Trade Center of Greater Philadelphia

The World Trade Center of Greater Philadelphia (WTCGP) is one of over 320 World Trade Centers in 89 countries around the globe. A non-profit and membership – based organization, the WTCGP accelerates global business growth for companies in Southeastern Pennsylvania and Southern New Jersey by providing customized, one-on-one trade counseling, market research, educational programs, trade mission and trade show support, business networking events, and powerful connections to customers and partners worldwide. Since 2002, the WTCGP has served as a catalyst for regional economic growth and job creation, helping area companies generate over $2B in incremental export sales, supporting over 26,000 jobs.  www.wtcphila.org